Oris Dental agrees further funding from Bridgepoint for next stage of growth

Bridgepoint has today announced that it will continue to back Oris Dental, a leading provider of dental care services across the Nordic region.

Following four years of support through the Bridgepoint Development Capital (BDC) III fund – a franchise focused on investing in lower mid-market businesses across Europe – Oris has more than trebled in size, whilst maintaining its position as a quality leader known for its dentist-centric culture. During the partnership, Oris has pursued an accelerated M&A agenda, has entered both the Swedish and Danish markets, and delivered above-market organic growth.

The Nordic dental services market remains highly fragmented, and significant opportunities exist for Oris to continue its journey of growth, focusing on clinical quality and operational improvements. As such, Bridgepoint has agreed to provide further funding to Oris via its BDC IV fund – which now becomes the new lead investor – continuing the two firms’ partnership to create a leading Nordic dental services platform. In addition, Oris and BDC are pleased to welcome Swedbank Robur Alternative Equity as a new investor and partner in the business going forward.

Eirik Aasland Salvesen, Chief Executive Officer at Oris Dental, said:

“Since 2020, Bridgepoint and Oris have enjoyed a successful partnership, driven in large part by Bridgepoint’s strong support of our quality-focused ambitions and dentist-centric culture. We are excited to continue to benefit from BDC’s backing as we look to further establish Oris’ position as a premier provider of dental services in the Nordic region.” 

Johan Gustafsson, Partner at Bridgepoint, said:

“With its clear focus on consistent, high-quality dental care and attracting, developing and retaining talent, Oris is clearly differentiated as a leader in its sector. The business has grown rapidly since our initial investment, and we are proud to continue to support the company in building out a leading Nordic high-quality dental platform.”

Financial details of the transaction are not disclosed. The transaction closed on 12 September 2024. 

We use strictly necessary cookies to make our site work. Currently the analytics cookies which allow us to collect information about how visitors use our website and help us to improve it; is defaulted to ‘InActive’, if you wish to turn this on you can do so through the Cookie Settings. Please be aware that by blocking some types of cookies it may impact your experience of the site and the services we are able to offer. For more information about any of these cookies and our use of them, or to change your settings at any time, please see Cookie Settings and Cookies Policy.